ADP-ribosylation factors (ARFs) comprise a family of ~20 kDa guanine nucleotide-binding proteins that were discovered as one of several cofactors required in cholera toxin-catalyzed ADP-ribosylation of G, the guanine nucleotide-binding protein responsible for stimulation of adenylyl cyclase, and was subsequently found to enhance all cholera toxin-catalyzed reactions and to directly interact with, and activate the toxin. ARF is dependent on GTP or its analogues for activity, binds GTP with high affinity in the presence of dimyristoylphosphatidylcholine/cholate and contains consensus sequences for GTP-binding and hydrolysis. Six mammalian family members have been identified which have been classified into three groups (Class I, II, and III) based on size, deduced amino acid sequence identity, phylogenetic analysis and gene structure. ARFs are ubiquitous among eukaryotes, with a deduced amino acid sequence that is highly conserved across diverse species. They have recently been shown to associate with phospholipid and Golgi membranes in a GTP-dependent manner and are involved in regulating vesicular transport. (Mol Cell Biochem 138: 157-166, 1994) 
Introduction
ADP-ribosylation factors are ~20 kDa guanine nucleotidebinding proteins that were initially discovered because they are cofactors for cholera toxin's enzymatic activities. Cholera toxin is a hetero-oligomeric protein secreted by I3brio cholerae and composed of oneA and five B subunits, the latter forming the cell membrane binding domain [ 1, 2] . The active A1 peptide (CTA1) is generated after reduction of a disulfide bond that links it to theA2 polypeptide [3, 4] . CTA1 is responsible for cholera toxin's enzymatic activities [5] .
These include (i) NAD hydrolysis toADP-ribose and nicotinamide [6] ; (ii) transfer of ADP-ribose to free arginine and simple guanidino compounds [7, 8] ; (iii) ADP-ribosylation ofnonspecific proteins, presumably due to available arginine residues which serve as toxin substrates [9] ; (iv) auto-ADPribosylation of CTA1 [ 10, 11 ] ; and (v) ADP-ribosylation of Gs~, the guanine nucleotide-binding protein responsible for stimulation of adenylyl cyclase [12] [13] [14] [15] . Gs~ is the substrate for cholera toxin in vivo and its modification by toxin underlies the pathogenesis of cholera by causing stimulation of adenylyl cyclase in intestinal mucosal cells [16, 17] .
Address for offprints: C. Welsh, Room 5N-307, Building 10, National Institute of Health, Bethesda, MD 20892, USA Activation of adenylyl cyclase by cholera toxin was shown to require NAD [ 18] , GTP or analogues [19] [20] [21] [22] , and certain cellular factors [19] . In membrane preparations, cholera toxin-catalyzed ADP-ribosylation of G also required GTP or nonhydrolyzable analogs and a cytosolic factor and correlated well with activation of adenylyl cyclase [23] . Two guanine nucleotide-binding sites were involved in this system: one responsible for activation of adenylyl cyclase and a distinct site which supported ADP-ribosylation but not cyclase activity [24] .
Various cellular factors that augmented cholera toxin catalyzedADP-ribosylation of G and/or activation of adenylyl cyclase were described [ 19, 23, 25--35] . These factors, which were isolated from numerous tissues and species, varied in size, biochemical properties, and subcellular localization.
Purification and biochemical characterization of ARF
A membrane-associated ADP-ribosylation factor (mARF) was purified 1800-fold from rabbit liver membranes [32] . Protein stability required detergent throughout the purification. ARF migrated as a doublet on SDS polyacrylamide gel electrophoresis and exhibited a M r of 21,500 [32] . GTP was required forARF to stimulate cholera toxin-catalyzedADPribosylation of G and ARF appeared to act catalytically in the assay [32] .
ARF purified from bovine brain membranes bound guanine nucleotides (GTP, GDP, and GTP~/S), but not adenine nucleotides [33] . High-affinity binding occurred in the presence of dimyristoylphosphatidylcholine (DMPC), MgCI2, and high ionic strength (0.8 M NaC1). The apparent dissociation constants for GTP and GDP were 90 and 40 nM, respectively. PurifiedARF contained approximately equimolar quantities of bound GDP, however no GTPase activity was detected in vitro. ARF-GTP was active in supporting cholera toxin-catalyzed ADP-ribosylation of G whereas ARF-GDP was inactive [33] .
ARF also enhanced Gs -independent reactions catalyzed by the toxin A 1 peptide (CTA 1) [34, 35] . These included the hydrolysis of NAD to nicotinamide andADP-ribose, the auto-ADP-ribosylation of CTA 1, andADP-ribosylation of simple guanidino compounds such as agmatine. In these reactions, ARF required GTP or a nonhydrolyzable analogue, whereas GDP and ATP analogues were ineffective [34, 35] . A model of a guanine nucleotide-binding protein cascade for cholera toxin activation of adenylyl cyclase has been proposed ( Fig. 1) . ARF, activated by GTP, interacts with, and activates the toxin A1 peptide which, in turn, catalyzes the ADPribosylation of G. In the presence of GTP, modified G persistently stimulates the adenylyl cyclase catalytic subunit. In this model, there is no direct interaction betweenARF and the toxin substrate.
Kinetic analysis ofARF-stimulated NAD:agmatineADPribosyltransferase activity of CTA 1 is consistent with direct interaction between ARF and the toxin subunit [36] . In the absence of detergents, ARF plus GTP lowered the apparent K m for NAD and agmatine. In the presence of 0.003% SDS, the concentration at which activity was maximal, the apparent K m values for both substrates were lowered further and the V a x was increased [36] . It was concluded that ARF is a direct allosteric activator of the toxin A1 subunit.
Since ARF's ability to stimulate cholera toxin-catalyzed reactions is dependent on GTP or its analogues, conditions optimal for high-affinity binding were determined [37] . Maximal binding of GTP by sARFII was observed in the presence of 3 mM DMPC and 0.2% cholate and required Mg 2 § but not NaC1 [37] . The apparent K D for GTP was 70 nM [37] . In the presence of low concentrations of SDS, conditions optimal for ARF stimulation of cholera toxin ADP-ribosyltransferase activity, minimal high affinity GTP binding by sARF II was observed [37] . Consistent with the binding data, the ECs0 for GTP in stimulation of cholera toxin ADP-ribosyltransferase activity was 5 gM in the presence of 0.003% SDS and 50 nM with DMPC/cholate. Thus, ARF stimulates cholera toxin-catalyzed reactions under conditions that support either high-(DMPC/cholate) or low-(SDS) affinity interactions with GTP.
ARF stimulation of cholera toxin reactions, both Gs -dependent and G -independent, was influenced by detergents and phospholipids [35] [36] [37] . DMPC was required for sARF plus GTP to stimulate maximallyADP-ribosylation of Gs~ but not auto-ADP-ribosylation of CTA1, which was somewhat inhibited [35, 37] . Maximal ARF stimulation of NAD: agmatineADP-ribosyltransferase activity was observed in the presence ofnondenaturing concentrations of SDS [36, 37] as was CTA1 auto-ADP-ribosylation [36, 38] .
In the presence of GTPyS and SDS, a fraction of ARF formed a complex with CTA1 [38] . Monomeric ARF separated from the complex by gel filtration was incapable of further complex formation. ARF-CTA1 complex stimulated auto-ADP-ribosylation to a greater extent than did the monomeric species, which exhibited clearly different substrate specificities [38] . No ARF-CTA 1 complex was formed during incubation with GTP~/S and DMPC/cholate. ARF, however, became aggregated under these conditions and was more active in stimulating cholera toxinADP-ribosylation of added substrates than auto-ADP-ribosylation of CTA1 [38] . These studies may provide a biochemical basis for the observed effects of detergents and phospholipids on substrate specificity.
Six mammalianARF family members have been identified through molecular cloning (see section on Molecular Characterization of ARF for complete discussion) and each of these has been expressed in bacteria [39] [40] [41] . Purified recombinant ARFs (rARFs) each stimulated cholera toxin- catalyzedADP-ribosyltransferase activity, using either G or agmatine as substrate. Individual differences were noted, however, in the conditions under which maximal activity was observed. Whereas rARFs 1-5 required DMPC/cholate for activity, rARF 6 was active in the presence of SDS, DMPC/ cholate, cholate alone, and in the absence of detergents and lipids [41] . Other differences observed between individual ARFs included sensitivity to high ionic strength, the ECs0 for GTP, and the requirement for Mg 2 § in binding guanine nucleotides [39, 41] . Differences in biochemical properties noted during early characterization and purification of factors required for cholera toxin activation may be related to such differences among individual ARFs.
ARF developmental expression
Expression of ARF proteins differs with developmental stage in some tissues, sARF t and sARF II (two forms purified from bovine brain) expression was studied in post-natal rat brain cytosol [42] . The level of immunoreactive sARF II relative to sARF I increased between postnatal days 2 and 10. The level ofARF 3 mRNA increased with age while there were simultaneous decreases in levels ofARF 2 and 4 mRNAs and ARF 1, 5, and 6 mRNAs were unchanged [42] .
Tissue-specific differences inARF 4 mRNA during development have also been observed [43] . A short form of ARF 4 mRNA (~1.1 kb) was found only in the testis of several species, along with the ubiquitous 1.8-kb mRNAI The 1.1 kbspecies resulted from use of the first of three putative polyadenylation signals in the 3'-untranslated region [43] . During dewelopment of rat testis, the 1.1-kb mRNA did not appear until the 35th postnatal day, suggesting that appearance of the shorter message may be associated with a late stage ofspermatogenesis [43] , a suggestion corroborated by in situ hybridization.
Molecular characterization of ARF
There are at least six mammalianARFs based on isolation and sequencing of cDNA clones [40, 44--49] . ARF genes have also been cloned from yeast (yARFs 1 and 2) [44, 50] , Drosophila melanogaster (dARF 1) [51] , and the protozoan Giardia lamblia (gARF) [52] . With the exception of ARF 2, which has not been found in human or monkey [42, 48, 53] , the individual ARFs appear to be highly conserved across species (Table 1) . For example, the human and bovine deduced amino acid and coding region nucleotide sequences for ARF 1 are 100% and 91% identical, respectively [45] . The Giardia ARF gene encodes a protein of 191 amino acids 63-70% identical to mammalianARFs, remarkable conservation considering that the divergence of this protozoan from other eukaryotes has been estimated to be ~1.5 billion years ago [52] . Table 1 highlights the conservation ofnucleotide and deduced amino acid sequences among individual ARF family members. Based on these comparisons, the mammalian ARFs have been assigned to three classes. Class I ARFs (ARFs 1, 2, and 3) are 95-96% identical to each other in deduced amino acid sequence, 79--80% identical to Class II and 68--69% identical to Class IIIARFs. Class IARFs are 181 amino acids in length. Class II is composed ofARFs 4 and 5 which contain 180 amino acids and are 90% identical to each other. The sole known member of Class III is ARF 6, which has only 175 amino acids and is 64-69% identical to other mammalianARFs. Sequence differences among Classes I, II, and III are located primarily in the amino terminal region and carboxyl half of the proteins (Fig. 2) .
The classification of ARF proteins is corroborated by an evaluation of evolutionary relationships among ARF family members [48] . Phylogenetic analysis was performed using coding region nucleotide sequences of the individual ARFs and is shown in Fig. 3 . Branch points, indicating evolutionary divergence, correspond to each class ofmammalianARF and yARF 1.
The ARFs represent distinct gene products. Each of the Class I ARF genes has been cloned and its structure determined (Fig. 4) [54] [55] [56] . Each of the genes contains five exons and four introns. The first exon is untranslated and translation initiation is located in exon 2. The consensus sequences for GTP binding and hydrolysis, which are identical in all mammalian ARFs, are encoded in separate exons. The sequence GLDAAGK, the putative phosphate binding loop, is encoded in exon 2 and DVGG, which is likely involved in Mg 2 § coordination, in exon 3. The sequence encoding NKQD (important in guanine ring-binding specificity) is separated by intron 4 into exons 4 and 5 between the codons for glutamine and aspartate. Exon/intron boundaries occur at identical sites within the coding regions of all three genes (Fig. 4) . Each of the 5'-untranslated regions contains multiple transcription initiation sites, multiple potential Sp 1 binding sites, and no TATA box, similar to promoters of housekeeping genes [54] [55] [56] .
ADrosophila ARF gene, dARF 1, was categorized as Class I based on a high degree of homology with mammalian ARFs 1-3 [51 ] . Two introns in the Drosophila gene contained splice sites very similar to the exon/intron boundaries in the mammalian Class I genes [51] . Gene structure in at least Class I ARFs, thus appears to be conserved across rather distantly related species.
The promoters ofARFs 2 and 3 both have regions that may be important for regulation [56, 57] . The ARF 2 promoter contains six inverted CCAAT motifs unlike those ofARFs 1 and 3 [54] [55] [56] and the functional regulatory region of the promoter includes a region containing one of these motifs. Whether this region is important in the species-specific and developmentally regulated expression patterns noted previously is an intriguing speculation, which requires further investigation. The ARF 3 promoter region contains a palindromic sequence important for transcription activity, which binds a protein from nuclear extracts [57] . A mutated palindromic sequence, which failed to compete for binding of the nuclear factor, had reduced transcription activity when linked -100  96  96  80  80  68  77  70  bARF 1  91  -96  96  80  80  68  77  70  bARF2  79  80  -95  80  80  69  77  70  hARF3  84  84  80  -79  79  68  76  69  hARF4  67  68  68  71  -90  64  72  69  hARF5  75  73  71  73  77  -64  69  69  hARF6  68  69  64  66  60  65  -65  63  yARFI  64  66  66  65  67  64  60  -62  gARF  65  67  62  64  61  66  62 67 -
Comparison of amino acid and nucleotide sequences of ARF family proteins. Percentage identity of deduced amino acid sequences is above the diagonal and of coding region nucleotide sequences below. See Fig. 2 to a reporter gene. The identity of this factor and its role in regulating ARF expression, and other TATA-less promoters, is unknown.
ARF protein structure
Through sequence comparisons with other GTPases, such as ras, certain functional domains in ARFs have been inferred. All of the ARF gene products contain the consensus sequences for GTP binding and hydrolysis [58] . These are 100% identical among the mammalian ARFs with minimal and usually conservative differences in yeast and Giardia ARFs (Fig. 2) . Like G o and Gi, many of the ARFs undergo N-terminal modification by myristoyl CoA:protein N-myristoyltransferase (NMT) [63--65] . Each of the ARFs contains a glycine in the first position, following the initiating methionine, which is the required substrate for NMT, although neighboring amino acids also influence substrate suitability [66] . Nterminal myristoylation is necessary for ARF to associate with Golgi membranes [63] where it functions in protein trafficking via vesicular transport. In contrast, ras proteins undergo carboxyl terminal processing including farnesylation, carboxy methylation, and palmitoylation which is similarly required for membrane association. Thus, ARF appears to have more in common with G protein alpha subunits than with other small GTPases when comparing GTPbinding consensus sequences and post-translational modification.
ARF structure and function analysis has focused on the amino terminus since it is the site of covalent lipid modification. CD spectral studies revealed that a peptide composed of the first 16 amino acids of ARF 1 (excluding the initial methionine) would likely form an alpha helix in a hydrophobic but not an aqueous environment [67] . Myristoylation of the amino-terminal glycine of the peptide stabilized the {x helical structure even in an aqueous solution. Furthermore, anARF deletion mutant, lacking the amino-terminal 17 residues ([AI-17]mARFlp) retained the ability to bind GTPyS but no longer required DMPC/cholate to do so [67] . Amino-terminal ~t helix formation may, therefore, influence the binding or release of guanine nucleotides by ARF. To what extent the myristoylation requirement for membrane association [63] reflects the need for cx helix formation is unknown.
ARD 1 is a 64-kDa protein, recently identified by eDNA cloning whose carboxyl terminal ~18 kDa is highly homologous to known mammalian ARFs but lacks sequence corresponding to the amino-terminal 15 amino acids [68] . Although previous studies had suggested that the amino terminus is critical for ARF activity [67] , ARD 1 stimulated cholera toxin ADP-ribosyltransferase activity in a GTP-dependent fashion in the presence of Tween 20 but not other lipids and detergents including DMPC/cholate. These studies clearly indicate that the amino terminal sequence is not responsible forARF activity, although it may be involved with phospholipid interaction.
ARF's role in vesicular transport
Accumulating evidence has implicatedARF as one of a growing number of GTPases for which a role in intracellular protein transport has been recognized. In Saccharomyces cerevisiae, disruption of the yARF 1 gene, which accounts for 90% of ARF protein, caused a defect in invertase secretion with intraeellular accumulation of incompletely glycosylated invertase [69] .
In in vitro studiesARF shifts between cytosolic and membrane compartments in a guanine nucleotide-dependent cycle. In the presence of nonhydrolyzable GTP analogues, cytosolic ARF associates with membranes or anionic phospholipid vesicles [70, 71 ] . In NRK cells, ARF bound to Golgi membranes in the presence of GTP),S, an action inhibited by prior treatment with brefeldin A [72] . Brefeldin A is a fungal metabolite that disrupts Golgi architecture and blocks secretion [73, 74] .
Serafini et al. [75] have identifiedARF as a coat protein, along with et-, 13-, 3% and 6-COPs, major constituents of the non-clathrin coat of Golgi-derived vesicles. ARF was found associated with coated vesicles, which originate from the budding surface of Golgi membranes, and not with uncoated vesicles, which had bound to, but not fused with, the target Golgi membranes. ARF was also required for the GTP~,Sdependent binding of fI-COP, and therefore, presumably, the coat protein complex, the 'coatomer' [76] .
Golgi-localized proteins that regulate the activation state of ARF and thus, its subcellular localization have been detected. A protein that enhanced the exchange of GDP bound to ARF with cytosolic GTP [77, 78] permitted ARF to associate with Golgi membranes. Rapid hydrolysis ofthe~/-phosphate ofARF-bound GTP occurred after the exchange reaction followed by release of ARF to the cytosolic fraction [77] . Subsequent studies revealed that individual ARFs differ in their subcellular localization and the conditions that promote membrane association [79, 80] . In addition, differences in the sensitivity to brefeldin A among ARF proteins have been reported [80] .
The evidence supports a model for ARF's role in vesicular transport as proposed by Serafini et al. [75] in whichARF binds to the surface of Golgi membranes through interaction with a Golgi-localized exchange protein. ARF-GTP is generated which is competent to associate with membrane lipids. Coat assembly and budding ensues until destabilization of 163 the vesicle coat is triggered by the formation of ARF-GDP by an ARF-specific GTPase-activating protein (GAP) at the target membrane. Components of the vesicle coat and ARF-GDP are released and recycled. ARF has also been implicated in other events involving vesicular fusion including endoplasmic reticulum to cis-Golgi transport [81 ] , endosome fusion during endocytosis [82] , and nuclear vesicle fusion following mitosis [83] . Specificity in targeting in each of these pathways may rely on individual ARFs interacting with specifically localized exchange proteins and GAPs.
Summary
ARF was discovered because of its role as a cofactor for cholera toxin-catalyzedADP-ribosylation of Gs. ARF itself was found to be a GTP-binding protein and a direct allosteric activator of all of the toxin's catalytic activities. The ARFs are a family of highly homologous proteins that are conserved both structurally and functionally across distantly related eukaryotes and are distinct from other GTP-binding proteins. Biochemical features which distinguishARFs include a relative dependence on phospholipids for GTP binding and activity, little or no intrinsic GTPase activity, and amino-terminal modification by N-myristoyltransferase. In vivo, ARF has been implicated in the regulation of vesicular transport through a guanine nucleotide-dependent cycle of association with and release from Golgi membranes. ARF has been identified as a coat protein andARF-specific regulatory proteins which catalyze guanine nucleotide exchange and accelerate GTPase activity have been detected on Golgi membranes. UnderstandingARF function and regulation will be important in elucidating mechanisms of vesicular transport.
